Innovative Solutions in Pre-Filled Syringes for Biologics and Ophthalmic Applications

Selecting the right pre-filled syringe for biologics and ophthalmic applications, covering plasma coating, viscosity, compatibility and analytics.
Date
July 11th, 2024
Time
4pm (CET) / 10am (ET)
Presented by:

About This Webinar.

The pre-filled syringes market has grown rapidly in recent years as a result of converging factors: the vast biologics market, a growing number of biosimilar entrants, the ongoing rise of self-administration, and rising chronic illness due to ageing populations.

There is not a solution that fits all the challenges. For this reason, Pharma Companies need tailored syringes fit for each intended uses.

 

In this webinar, Enrico Barichello, Product Manager for Syringe Platform in Stevanato Group and Alan Xu, Product Manager for Analytical Services in Stevanato Group, will be discussing the best strategy between customers and suppliers to select the right container based on the key features of the combination product.

Reserve Your Seat

Built Around the
Challenges You Face.

Addressed Challenges
Streamlining the integration of primary drug containers and delivery systems through early analytical services to accelerate time-to-market decisions. 
Stabilising complex, sensitive biologics including mRNA, viral vectors, and monoclonal antibodies in prefillable syringes over extended storage periods. 
Meeting the dimensional and tolerance requirements of new-generation auto-injectors as biologics programmes transition from hospital to home-care settings. 
Delivering high-concentration biologic formulations accurately despite the viscosity challenges they introduce during subcutaneous drug administration. 
WHAT YOU WILL LEARN
Understand how early-stage analytical services simplify the combination product journey from design selection through to commercial market launch. 
Learn how specialised prefillable syringes with advanced coatings meet the stability and resilience requirements of protein-based and high-viscosity drugs. 
Discover how auto-injectors designed for patient centricity depend on specialised primary containers to ensure safe and effective home-care drug delivery. 
Learn how syringe options with increased internal needle diameter help overcome viscosity challenges in high-concentration biologic formulations. 
Prefilled syringe webinar

Enrico Barichello

Product Manager, Syringe Platform – DCS Glass, Stevanato Group

Enrico Barichello acquired broad-spectrum skills in technical concepts and complex processes. He joined Stevanato Group in 2017 as a Product Management Specialist for the Syringe platform. He defined and coordinated all the activities required to bring the products to market, bridging gaps between different company functions and aligning the involved teams. He has been responsible for the roadmap and execution of the innovative platform Alba®. Since 2023 he is Product Manager for the Glass Syringe Platform.

Alan Xu

Product Manager for Analytical Services, Stevanato Group

Alan Xu is Stevanato Group’s Product Manager for Analytical Services and has been with the company since 2019. He is a primary contact for pharmaceutical and contract organizations around the world who are interested in leveraging TEC’s expertise to de-risk and optimize their combination products. Alan also investigates new analytical opportunities like low temperature CCIT and promotes awareness on ways to improve product quality and patient safety using data-driven methods. Prior to Stevanato Group, he was an Engineering Manager leading the development and pilot production of a novel primary container for a novel auto-injector specializing in biologics. He holds a degree in Mechanical Engineering from the Massachusetts Institute of Technology (MIT).

Meet the Speaker.

Free to attend.
Limited places.

July 11th, 2024

4pm (CET) / 10am (ET)

Reserve Your Seat

<span>By ticking this box, you agree to the privacy policy of <a href=”https://www.stevanatogroup.com/it/privacy-policy/” style=”color:white; text-decoration: underline;” target=”_blank”>Stevanato Group</a> consenting to receiving communications related to this topic and other products or services within their portfolio</span>